Researchers at the University of Leicester and Glenfield Hospital have successfully used a novel "paper-clip" sized vascular coupling device to tackle resistant high blood pressure.
The operation was carried out on Monday 16 September at Glenfield Hospital by Professor André Ng, Professor of Cardiac Electrophysiology at the University of Leicester and Consultant Cardiologist at Glenfield Hospital.
The trial – called ROX CONTROL HTN - is a prospective randomized international multicentre study designed to evaluate a novel treatment, called the ROX coupler, in patients with resistant hypertension. The ROX Coupler is a small metal stent made of nitinol which when deployed, acts like a "paper-clip" joining an artery and a vein together in the groin area (called iliac vessels). This allows blood to flow between the high pressure artery and the low pressure vein. The Coupler is inserted and put in place via key-hole procedure at the groin under local anaesthesia.
Professor Ng said: "Our research at the University of Leicester aims to find novel ways of tackling hypertension.
"We carried out this procedure on our first patient, a 56 year old male, here at Glenfield Hospital, which went extremely well. After the initial preparation, it took me and my team just over an hour to put the implant in place. Almost immediately the patient's blood pressure went down to more acceptable levels which we anticipate to further improve with time. The patient was kept overnight for observation but will be discharged the following day if everything is well."
"Results from the pilot study already done on this new technology look promising. There is a very early response with a reduction in blood pressure in resistant hypertensive patients which appears to be maintained in medium term at least. We hope to uncover the mechanisms by which this works and that is the whole purpose of the randomised trial to establish the safety of this new technology, the characteristics of the response and more insight into the way it works.
The patient, from Leicester, said: "The procedure is remarkable. I know it is still early days but I have already seen a significant reduction in my blood pressure points. I am amazed!"
Professor Ng added: "Uncontrolled hypertension can lead to many other medical conditions with dire consequences. Patients with resistant hypertension have blood pressure way above normally accepted levels despite multiple medications in combination. New forms of effective treatment are always welcome and that is the reason why we, at the University of Leicester and Leicester's Hospitals, are conducting properly designed trials to assess the efficacy.
"We hope this groundbreaking treatment will provide a lifeline to patients who have had all the drugs prescribed and yet their blood pressure remains uncontrolled. It is an example of how research at the University of Leicester is being applied to benefit patients at Glenfield Hospital. We also really like the fact that the procedure is reversible."
Professor Ng said: "It is clear that a novel approach beyond the use of drugs needs to be developed to treat this condition. That is why this trial between the University of Leicester and Leicester's Hospitals is so important."
Explore further: NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
Medical Xpress on facebook
Related Stories
Renal denervation achieves significant and sustained blood pressure reduction
Aug 27, 2012
Renal denervation leads to significant and sustained blood pressure reduction for up to 18 months in patients with treatment resistant hypertension, according to research presented at ESC Congress 2012. The new clinical data ...
Revolutionary operation performed live for heart rhythm congress
Oct 21, 2008
A revolutionary heart operation technique using cutting edge technology will be performed on Monday 20 October and broadcast live to delegates at the Heart Rhythm Congress 2008 taking place in Birmingham.
New study could help stroke victims
Apr 24, 2007
A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.
NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
Oct 25, 2012
Patients with hypertension whose blood pressure cannot be brought down to safe levels despite taking three or more medications may have some relief coming their way. An innovative, first-of-its-kind clinical trial for a device ...
Robo-op marks new world first for heart procedure
Nov 15, 2010
The world's first remote heart procedure, using a robotic arm alongside 3-D mapping, is due to take place at Glenfield Hospital in Leicester.
Recommended for you
Increased QRS duration on ECG tied to cardiovascular mortality
18 hours ago
(HealthDay)—Increased QRS duration on electrocardiogram (ECG) is an independent predictor of cardiovascular mortality, according to a study published in the Sept. 1 issue of The American Journal of Cardiology.
Researchers envision switching a heart beat on and off with light
23 hours ago
With a few flicks of a light switch—on-off-on-off—Stanford University's Oscar Abilez is one step closer to changing the lives of millions.
National registry report shows increase in radial stenting, other CV trends
Sep 18, 2013
Cardiologists are increasingly accessing coronary arteries by way of the wrist rather than the groin to insert life-saving stents into patients with blocked arteries, according to the first broad report of the American College ...
UCLA doctors successfully 'vacuum' two-foot blood clot out of patient's heart
Sep 18, 2013
Todd Dunlap, 62, arrived at Ronald Reagan UCLA Medical Center's emergency room on Aug. 8 suffering from shortness of breath, fatigue and extreme cold. When a CT scan revealed a 24-inch clot stretching from his legs into his ...
Different hormone therapy formulations may pose different risks for heart attack and stroke
Sep 18, 2013
Post-menopausal women whose doctors prescribe hormone replacement therapy for severe hot flashes and other menopause symptoms may want to consider taking low doses of Food and Drug Administration-approved bioidentical forms ...
Researchers creating next generation prosthetic heart valves
Sep 18, 2013
Researchers in the School of Biomedical Engineering and the Department of Mechanical Engineering at Colorado State University are working on developing replacement heart valves that will be superior to current mechanical ...
User comments
© Medical Xpress 2011-2013, Phys.org network
Researchers at the University of Leicester and Glenfield Hospital have successfully used a novel "paper-clip" sized vascular coupling device to tackle resistant high blood pressure.
The operation was carried out on Monday 16 September at Glenfield Hospital by Professor André Ng, Professor of Cardiac Electrophysiology at the University of Leicester and Consultant Cardiologist at Glenfield Hospital.
The trial – called ROX CONTROL HTN - is a prospective randomized international multicentre study designed to evaluate a novel treatment, called the ROX coupler, in patients with resistant hypertension. The ROX Coupler is a small metal stent made of nitinol which when deployed, acts like a "paper-clip" joining an artery and a vein together in the groin area (called iliac vessels). This allows blood to flow between the high pressure artery and the low pressure vein. The Coupler is inserted and put in place via key-hole procedure at the groin under local anaesthesia.
Professor Ng said: "Our research at the University of Leicester aims to find novel ways of tackling hypertension.
"We carried out this procedure on our first patient, a 56 year old male, here at Glenfield Hospital, which went extremely well. After the initial preparation, it took me and my team just over an hour to put the implant in place. Almost immediately the patient's blood pressure went down to more acceptable levels which we anticipate to further improve with time. The patient was kept overnight for observation but will be discharged the following day if everything is well."
"Results from the pilot study already done on this new technology look promising. There is a very early response with a reduction in blood pressure in resistant hypertensive patients which appears to be maintained in medium term at least. We hope to uncover the mechanisms by which this works and that is the whole purpose of the randomised trial to establish the safety of this new technology, the characteristics of the response and more insight into the way it works.
The patient, from Leicester, said: "The procedure is remarkable. I know it is still early days but I have already seen a significant reduction in my blood pressure points. I am amazed!"
Professor Ng added: "Uncontrolled hypertension can lead to many other medical conditions with dire consequences. Patients with resistant hypertension have blood pressure way above normally accepted levels despite multiple medications in combination. New forms of effective treatment are always welcome and that is the reason why we, at the University of Leicester and Leicester's Hospitals, are conducting properly designed trials to assess the efficacy.
"We hope this groundbreaking treatment will provide a lifeline to patients who have had all the drugs prescribed and yet their blood pressure remains uncontrolled. It is an example of how research at the University of Leicester is being applied to benefit patients at Glenfield Hospital. We also really like the fact that the procedure is reversible."
Professor Ng said: "It is clear that a novel approach beyond the use of drugs needs to be developed to treat this condition. That is why this trial between the University of Leicester and Leicester's Hospitals is so important."
Explore further: NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
Medical Xpress on facebook
Related Stories
Renal denervation achieves significant and sustained blood pressure reduction
Aug 27, 2012
Renal denervation leads to significant and sustained blood pressure reduction for up to 18 months in patients with treatment resistant hypertension, according to research presented at ESC Congress 2012. The new clinical data ...
Revolutionary operation performed live for heart rhythm congress
Oct 21, 2008
A revolutionary heart operation technique using cutting edge technology will be performed on Monday 20 October and broadcast live to delegates at the Heart Rhythm Congress 2008 taking place in Birmingham.
New study could help stroke victims
Apr 24, 2007
A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.
NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
Oct 25, 2012
Patients with hypertension whose blood pressure cannot be brought down to safe levels despite taking three or more medications may have some relief coming their way. An innovative, first-of-its-kind clinical trial for a device ...
Robo-op marks new world first for heart procedure
Nov 15, 2010
The world's first remote heart procedure, using a robotic arm alongside 3-D mapping, is due to take place at Glenfield Hospital in Leicester.
Recommended for you
Increased QRS duration on ECG tied to cardiovascular mortality
18 hours ago
(HealthDay)—Increased QRS duration on electrocardiogram (ECG) is an independent predictor of cardiovascular mortality, according to a study published in the Sept. 1 issue of The American Journal of Cardiology.
Researchers envision switching a heart beat on and off with light
23 hours ago
With a few flicks of a light switch—on-off-on-off—Stanford University's Oscar Abilez is one step closer to changing the lives of millions.
National registry report shows increase in radial stenting, other CV trends
Sep 18, 2013
Cardiologists are increasingly accessing coronary arteries by way of the wrist rather than the groin to insert life-saving stents into patients with blocked arteries, according to the first broad report of the American College ...
UCLA doctors successfully 'vacuum' two-foot blood clot out of patient's heart
Sep 18, 2013
Todd Dunlap, 62, arrived at Ronald Reagan UCLA Medical Center's emergency room on Aug. 8 suffering from shortness of breath, fatigue and extreme cold. When a CT scan revealed a 24-inch clot stretching from his legs into his ...
Different hormone therapy formulations may pose different risks for heart attack and stroke
Sep 18, 2013
Post-menopausal women whose doctors prescribe hormone replacement therapy for severe hot flashes and other menopause symptoms may want to consider taking low doses of Food and Drug Administration-approved bioidentical forms ...
Researchers creating next generation prosthetic heart valves
Sep 18, 2013
Researchers in the School of Biomedical Engineering and the Department of Mechanical Engineering at Colorado State University are working on developing replacement heart valves that will be superior to current mechanical ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment